The Prognostic Significance of Atrial Fibrillation and Left Atrium Size in Patients with Aortic Stenosis

Aim    Aortic stenosis increases left atrial (LA) pressure and may lead to its remodeling. This can cause supraventricular arrhythmia. The aim of this study was to determine if the size of the LA and the presence of atrial fibrillation are related to the prognosis of patients with aortic stenosis.
Material and methods    Clinical evaluation and standard transthoracic echocardiographic studies were performed in 397 patients with moderate to severe aortic stenosis.
Results    In all patients, LA dimension above the median (≥43 mm) was associated with a significantly higher risk of death [HR 1.79 (CL 1.06-3.03)] and a LA volume above the median of 80 ml was associated with a significantly higher risk of death [HR 2.44 (CI 1.12-5.33)]. The presence of atrial fibrillation was significantly associated with a higher risk of death (p <0.0001). The presence of atrial fibrillation [HR 1.69 (CI 1.02-2.86)], lower left ventricular ejection fraction [HR 1.23 (CI 1.04-1.45)], higher NYHA heart failure class [HR 4.15 (CI 1.40-13.20)] and renal failure [HR 2.10 (CI 1.31-3.56)] were independent risk factors of death in patients in aortic stenosis.
Conclusion    The size and volume of the LA and the occurrence of atrial fibrillation are important risk factors for death in patients with aortic stenosis. The presence of renal dysfunction, low left ventricular ejection fraction, high NYHA functional class and atrial fibrillation are independent risk factors of poor prognosis in patients with aortic stenosis.

1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. The Lancet. 2006;368(9540):1005–11. DOI: 10.1016/S0140-6736(06)69208-8

2. Abhayaratna WP, Seward JB, Appleton CP, Douglas PS, Oh JK, Tajik AJ et al. Left Atrial Size: physiologic determinants and clinical applications. Journal of the American College of Cardiology. 2006;47(12):2357–63. DOI: 10.1016/j.jacc.2006.02.048

3. Simek CL, Feldman MD, Haber HL, Wu CC, Jayaweera AR, Kaul S. Relationship between left ventricular wall thickness and left atrial size: Comparison with other measures of diastolic function. Journal of the American Society of Echocardiography. 1995;8(1):37–47. DOI: 10.1016/S0894-7317(05)80356-6

4. Rusinaru D, Bohbot Y, Kowalski C, Ringle A, Maréchaux S, Tribouilloy C. Left Atrial Volume and Mortality in Patients With Aortic Stenosis. Journal of the American Heart Association. 2017;6(11):e006615. DOI: 10.1161/JAHA.117.006615

5. Safaryan V.I., Zotova I.V., Koroleva O.S., Tipteva T.A., Zateyshchikov D.A. The left atrium remodeling is associated with adverse outcomes in unoperated degenerative aortic stenosis. Journal of Clinical Practice. 2018;9(2):12–9. DOI: 10.17816/clinpract09212-19

6. Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, Dokainish H, Edvardsen T et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography. 2016;29(4):277–314. DOI: 10.1016/j.echo.2016.01.011

7. Stortecky S, Buellesfeld L, Wenaweser P, Heg D, Pilgrim T, Khattab AA et al. Atrial Fibrillation and Aortic Stenosis: Impact on Clinical Outcomes Among Patients Undergoing Transcatheter Aortic Valve Implantation. Circulation: Cardiovascular Interventions. 2013;6(1):77–84. DOI: 10.1161/CIRCINTERVENTIONS.112.000124

8. Webb JG, Altwegg L, Boone RH, Cheung A, Ye J, Lichtenstein S et al. Transcatheter Aortic Valve Implantation: Impact on Clinical and Valve-Related Outcomes. Circulation. 2009;119(23):3009–16. DOI: 10.1161/CIRCULATIONAHA.108.837807

9. Buellesfeld L, Gerckens U, Schuler G, Bonan R, Kovac J, Serruys PW et al. 2-Year Follow-Up of Patients Undergoing Transcatheter Aortic Valve Implantation Using a Self-Expanding Valve Prosthesis. Journal of the American College of Cardiology. 2011;57(16):1650–7. DOI: 10.1016/j.jacc.2010.11.044

10. Philippart R, Brunet-Bernard A, Clementy N, Bourguignon T, Mirza A, Babuty D et al. Prognostic value of CHA2DS2-VASc score in patients with ‘non-valvular atrial fibrillation’ and valvular heart disease: the Loire Valley Atrial Fibrillation Project. European Heart Journal. 2015;36(28):1822–30. DOI: 10.1093/eurheartj/ehv163

11. Amin A, Houmsse A, Ishola A, Tyler J, Houmsse M. The current approach of atrial fibrillation management. Avicenna Journal of Medicine. 2016;6(1):8–16. DOI: 10.4103/2231-0770.173580

12. Losi M-A, Mancusi C, Midtbø H, Saeed S, De Simone G, Gerdts E. Impact of estimated left atrial volume on prognosis in patients with asymptomatic mild to moderate aortic valve stenosis. International Journal of Cardiology. 2019;297:121–5. DOI: 10.1016/j.ijcard.2019.10.004

13. Naito Y, Yamazaki K. Preoperative left atrial volume index predicts postoperative atrial fibrillation in patients with severe aortic valve stenosis. Journal of Anesthesia. 2013;27(5):699–704. DOI: 10.1007/s00540-013-1594-8

14. Morimoto J, Hozumi T, Takemoto K, Wada T, Maniwa N, Kashiwagi M et al. Preoperative left atrial minimum volume as a surrogate marker of post-operative symptoms in senile patients with aortic stenosis who underwent surgical aortic valve replacement. Journal of Cardiology. 2019;74(4):366–71. DOI: 10.1016/j.jjcc.2019.04.003

15. Benjamin EJ, D’Agostino RB, Belanger AJ, Wolf PA, Levy D. Left Atrial Size and the Risk of Stroke and Death: The Framingham Heart Study. Circulation. 1995;92(4):835–41. DOI: 10.1161/01.CIR.92.4.835

16. Carpenito M, Fanti D, Mega S, Benfari G, Bono MC, Rossi A et al. The Central Role of Left Atrium in Heart Failure. Frontiers in Cardiovascular Medicine. 2021;8:704762. DOI: 10.3389/fcvm.2021.704762

17. O’Connor K, Magne J, Rosca M, Piérard LA, Lancellotti P. Impact of Aortic Valve Stenosis on Left Atrial Phasic Function. The American Journal of Cardiology. 2010;106(8):1157–62. DOI: 10.1016/j.amjcard.2010.06.029

18. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e72–227. DOI: 10.1161/CIR.0000000000000923